What is the dosage of Takhzyro?

Takhzyro is available in 2 dosages, including 150 mg/ml Injection 2 ml and 150 mg/ml Prefilled Syringe 2 ml

What is Takhzyro made of?

Takhzyro contains lanadelumab which is a undefined

How is Takhzyro administered?

Takhzyro is administered as a Injectable

What is Takhzyro mechanism of action?

Takhzyro mechanism of action is

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Takhzyro

(lanadelumab)

2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro]2 ML lanadelumab-flyo 150 MG/ML Prefilled Syringe [Takhzyro]

NO BLACK BOX WARNING

Dosage & administration

For subcutaneous use only.

Recommended Dosage:

* Adult and pediatric patients 12 years of age and older: administer 300 mg every 2 weeks by the patient or caregiver. Dosing interval every 4 weeks may be considered in some patients.
* Pediatric patients 6 to less than 12 years of age: administer 150 mg every 2 weeks by a healthcare provider or caregiver. Dosing interval every 4 weeks may be considered in some patients.
* Pediatric patients 2 to less than 6 years of age: administer 150 mg every 4 weeks by a healthcare provider or caregiver.
* See Full Prescribing Information for Administration Instructions.

drug label

Takhzyro prescribing information

Have more Takhzyro questions?

Submit MSL Request

Learn More

Need to report a Takhzyro issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Takhzyro samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Takhzyro Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

Coverage Authorization Appeals

Formulary Exception Letter

Letter of Intent to Treat

Claim Denial Letter

Learn More

Benefits investigation

One Path Start Form

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Takhzyro Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

One Path Start Form

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Quick Start Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement